Greg Coffey Selected Research

Oral Administration

2/2012

Specific inhibition of spleen tyrosine kinase suppresses leukocyte immune function and inflammation in animal models of rheumatoid arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Greg Coffey Research Topics

Disease

5	Neoplasms (Cancer) 02/2017 - 02/2013
4	Lymphoma (Lymphomas) 02/2017 - 12/2011
3	Inflammation (Inflammations) 12/2014 - 02/2012
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 02/2017 - 02/2013
2	Experimental Arthritis 01/2017 - 12/2014
2	Rheumatoid Arthritis 12/2013 - 02/2012
1	Autoimmune Diseases (Autoimmune Disease) 01/2017
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2015
1	Splenomegaly 12/2014
1	B-Cell Leukemia (Leukemia, B Cell) 12/2014
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2013

Drug/Important Bio-Agent (IBA)

4	Syk KinaseIBA 01/2017 - 02/2012
3	4- (cyclopropylamino)- 2- ((4- (4- (ethylsulfonyl)piperazin- 1- yl)phenyl)amino)pyrimidine- 5- carboxamideIBA 02/2017 - 12/2014
3	4- (3- (2H- 1,2,3- triazol- 2- yl)phenylamino)- 2- (2- aminocyclohexylamino)pyrimidine- 5- carboxamideIBA 01/2017 - 02/2013
3	Phosphotransferases (Kinase)IBA 12/2015 - 02/2013
1	ibrutinibIBA 02/2017
1	AutoantibodiesIBA 12/2014
1	B-Cell Antigen Receptors (B Cell Antigen Receptors)IBA 12/2014
1	Methotrexate (Mexate)FDA LinkGeneric 12/2013
1	Blood Proteins (Serum Proteins)IBA 12/2013
1	fludarabineIBA 02/2013
1	2- (2- aminocyclohexylamino)- 4- (m- tolylamino)pyrimidine- 5- carboxamideIBA 12/2011

Therapy/Procedure

1	Oral Administration 02/2012
1	Therapeutics 12/2011